These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 15275790

  • 1. Chronic fentanyl or buprenorphine infusion in the mouse: similar analgesic profile but different effects on immune responses.
    Martucci C, Panerai AE, Sacerdote P.
    Pain; 2004 Jul; 110(1-2):385-92. PubMed ID: 15275790
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B, Christoph T, Strassburger W, Friderichs E.
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Buprenorphine ameliorates the effect of surgery on hypothalamus-pituitary-adrenal axis, natural killer cell activity and metastatic colonization in rats in comparison with morphine or fentanyl treatment.
    Franchi S, Panerai AE, Sacerdote P.
    Brain Behav Immun; 2007 Aug; 21(6):767-74. PubMed ID: 17291715
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA, Holtzman SG.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 14. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R, Nuijten M, Nautrup BP.
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of local administration of transdermal fentanyl on peripheral opioid analgesia.
    Worrich S, Schuler G, Janicki PK.
    Pain Med; 2007 Jul; 8(1):41-7. PubMed ID: 17244103
    [Abstract] [Full Text] [Related]

  • 17. Fentanyl-related 4-heteroanilido piperidine OHM3295 augments splenic natural killer activity and induces analgesia through opioid receptor pathways.
    Baker ML, Brockunier LL, Bagley JR, France CP, Carr DJ.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1285-92. PubMed ID: 7562500
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.